| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.13 | 0.008 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.095 | 0.04 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.092 | 0.05 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.088 | 0.06 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.077 | 0.06 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.076 | 0.07 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.078 | 0.08 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.081 | 0.09 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.056 | 0.2 |